1. Home
  2. CYBN vs DOGZ Comparison

CYBN vs DOGZ Comparison

Compare CYBN & DOGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • DOGZ
  • Stock Information
  • Founded
  • CYBN 2019
  • DOGZ 2003
  • Country
  • CYBN Canada
  • DOGZ China
  • Employees
  • CYBN N/A
  • DOGZ N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • DOGZ Miscellaneous manufacturing industries
  • Sector
  • CYBN Health Care
  • DOGZ Consumer Discretionary
  • Exchange
  • CYBN Nasdaq
  • DOGZ Nasdaq
  • Market Cap
  • CYBN 176.0M
  • DOGZ 202.2M
  • IPO Year
  • CYBN N/A
  • DOGZ 2017
  • Fundamental
  • Price
  • CYBN $7.11
  • DOGZ $15.60
  • Analyst Decision
  • CYBN Strong Buy
  • DOGZ
  • Analyst Count
  • CYBN 3
  • DOGZ 0
  • Target Price
  • CYBN $85.00
  • DOGZ N/A
  • AVG Volume (30 Days)
  • CYBN 351.0K
  • DOGZ 263.0K
  • Earning Date
  • CYBN 08-13-2025
  • DOGZ 03-31-2025
  • Dividend Yield
  • CYBN N/A
  • DOGZ N/A
  • EPS Growth
  • CYBN N/A
  • DOGZ N/A
  • EPS
  • CYBN N/A
  • DOGZ N/A
  • Revenue
  • CYBN N/A
  • DOGZ $20,258,926.00
  • Revenue This Year
  • CYBN N/A
  • DOGZ N/A
  • Revenue Next Year
  • CYBN N/A
  • DOGZ N/A
  • P/E Ratio
  • CYBN N/A
  • DOGZ N/A
  • Revenue Growth
  • CYBN N/A
  • DOGZ 46.16
  • 52 Week Low
  • CYBN $4.81
  • DOGZ $7.16
  • 52 Week High
  • CYBN $13.88
  • DOGZ $58.50
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 45.43
  • DOGZ 66.21
  • Support Level
  • CYBN $6.36
  • DOGZ $13.17
  • Resistance Level
  • CYBN $7.75
  • DOGZ $16.59
  • Average True Range (ATR)
  • CYBN 0.34
  • DOGZ 1.68
  • MACD
  • CYBN -0.04
  • DOGZ 1.08
  • Stochastic Oscillator
  • CYBN 51.95
  • DOGZ 89.50

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

Share on Social Networks: